Jiang L, Niu S, Clines K L, Burke D J, Sturgill T W
Department of Pharmacology, University of Virginia Health Sciences Center, PO Box 800735, Charlottesville, VA 22908, USA.
Mol Genet Genomics. 2004 Mar;271(2):208-19. doi: 10.1007/s00438-003-0972-6. Epub 2004 Jan 21.
Rck2p is a Ser/Thr kinase that binds to, and is activated by, Hog1p. Expression of the MAP kinase kinase Pbs2pDD from a GAL1-driven plasmid hyperactivates the HOG MAP kinase pathway, and leads to cessation of growth. This toxic effect is reduced by deletion of RCK2. We studied the structural and functional basis for the role of Rck2p in mediating the growth arrest phenotype associated with overexpression of Pbs2pDD. Rck2p kinase activity is required for the effect, because Rck2p(Delta487-610), as well as full-length Rck2p, is toxic with Pbs2pDD, but kinase-defective versions of either protein with a K201R mutation are not. Thus, the C-terminal portion of Rck2p is not required provided the protein is activated by removal of the autoinhibitory domain. Relief of inhibition in Rck2p normally requires phosphorylation by Hog1p, and Rck2p contains a putative MAP kinase docking site (TILQR589R590KKVQ) in its C-terminal segment. The Rck2p double mutant R589A/R590A expressed from a centromeric plasmid did not detectably bind Hog1p-GFP and was functionally inactive in mediating the toxic effect of Pbs2pDD, equivalent to an RCK2 deletion. However, overexpression of Rck2p R589A/R590A from a multicopy plasmid restored function. In contrast, RCK2-K201R acted as a multicopy suppressor of PBS2DD, markedly reducing its toxicity. This suppressor activity required the K201R mutation, and the effect was largely lost when the docking site was mutated, suggesting suppression by inhibition of Hog1p functions. We also studied the effect of replacing the predicted T379 and established S520 phosphorylation sites in Rck2p by glutamic acid. Surprisingly, the T379E mutant markedly reduced Pbs2pDD toxicity, and toxicity was only partially rescued by S520E. Rck2 T379E was sufficiently inactive in an rck2Delta strain to allow some cells to survive PBS2DD toxicity even when overexpressed. The significance of these findings for our understanding of Rck2p function is discussed.
Rck2p是一种丝氨酸/苏氨酸激酶,它与Hog1p结合并被其激活。由GAL1驱动的质粒表达的促分裂原活化蛋白激酶激酶Pbs2pDD会过度激活HOG促分裂原活化蛋白激酶途径,并导致生长停止。RCK2的缺失可减轻这种毒性作用。我们研究了Rck2p在介导与Pbs2pDD过表达相关的生长停滞表型中所起作用的结构和功能基础。这种作用需要Rck2p激酶活性,因为Rck2p(Δ487 - 610)以及全长Rck2p与Pbs2pDD一起时具有毒性,但带有K201R突变的这两种蛋白的激酶缺陷型则没有毒性。因此,如果通过去除自身抑制结构域激活该蛋白,则不需要Rck2p的C末端部分。Rck2p中抑制作用的解除通常需要Hog1p进行磷酸化,并且Rck2p在其C末端片段中含有一个假定的促分裂原活化蛋白激酶对接位点(TILQR589R590KKVQ)。从着丝粒质粒表达的Rck2p双突变体R589A/R590A无法检测到与Hog1p - GFP结合,并且在介导Pbs2pDD的毒性作用方面功能失活,等同于RCK2缺失。然而,从多拷贝质粒过表达Rck2p R589A/R590A可恢复其功能。相比之下,RCK2 - K201R作为PBS2DD的多拷贝抑制子,显著降低了其毒性。这种抑制活性需要K201R突变,并且当对接位点发生突变时,这种作用基本丧失,表明是通过抑制Hog1p功能来实现抑制作用。我们还研究了用谷氨酸替代Rck2p中预测的T379和已确定的S520磷酸化位点的效果。令人惊讶的是,T379E突变体显著降低了Pbs2pDD的毒性,而S520E仅部分挽救了毒性。在rck2Δ菌株中,Rck2 T379E的活性足够低,以至于即使过表达时,也能使一些细胞在PBS2DD毒性下存活。讨论了这些发现对于我们理解Rck2p功能的意义。